OrthoPediatrics generated a total of $52.4 million in revenue in the first quarter of 2025, up 17% from $44.7 million in first quarter revenue in 2024.
Here are six additional things to know about the company’s Q1 revenue, according to a May 7 press release:
1. OrthoPediatrics treated nearly 39,000 patients in Q1.
2. Domestic revenue increased 19%, for the company, while international revenue increased 11%.
3. Trauma and deformity revenue grew 14% and worldwide scoliosis revenue grew 34% in the first quarter of 2025 compared to the first quarter of 2024.
4. OrthoPediatrics adjusted its full year 2025 revenue guidance to $236 million to $242 million from $235.0 million to $242.0 million, representing growth of 15% to 18% compared to prior year.
5. Total other income was $500,000 for the first quarter of 2025, compared to other expenses of $600,000 for the same period last year.
6. Net loss for the first quarter of 2025 was $10.7 million, compared to $7.8 million for the same period last year.
